Related Experiment Video
Updated: Apr 21, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Perimenopausal bleeding: Patterns, pathology, response to progestins and clinical outcome
1a Department of Obstetrics and Gynecology , Faculty of Medicine, Menoufia University , Shibin Elkom, Menoufia , Egypt.
Perimenopausal abnormal uterine bleeding often stems from dysfunctional causes, but organic endometrial lesions require careful diagnosis. Progestin therapy shows promise for regression in simple endometrial hyperplasia without atypia.
Area of Science:
- Gynecology
- Reproductive Endocrinology
Background:
- Abnormal uterine bleeding (AUB) is common in perimenopausal women.
- While often dysfunctional, organic endometrial lesions necessitate accurate diagnosis and management.
Purpose of the Study:
- To evaluate the response to progestin therapy in perimenopausal patients with endometrial lesions.
- To determine the clinical outcomes of abnormal uterine bleeding in this demographic.
Main Methods:
- Prospective observational study of 400 perimenopausal patients with abnormal uterine bleeding and diagnosed endometrial lesions.
- Histopathological diagnosis and follow-up of patients receiving progestin therapy.
Main Results:
- Menorrhagia was the most frequent bleeding pattern (67.5%).
- Simple endometrial hyperplasia without atypia was the most common pathology (31%).
- Progestin therapy led to regression in 70.4% of non-atypical hyperplasia cases, with persistence in 26.7% and progression to atypia in 2.9%.
Conclusions:
- Perimenopausal bleeding has diverse origins, with organic endometrial lesions being a significant concern.
- Endometrial sampling and expert interpretation are crucial for optimal clinical outcomes.
- Low-dose progestin therapy ( < 20 mg/day) for 4-5 months appears effective for non-atypical endometrial hyperplasia.
Related Concept Videos
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Menses Phase
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
The Menstrual Cycle
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
Proliferative Phase
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
Disorders of the Female Reproductive System
